Mark Bodenrader - Title: Senior Vice President, Finance and Chief Accounting Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Senior Vice President, Finance and Chief Accounting Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Bodenrader - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Mark Bodenrader for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 24,852 $1.05 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 17,724 $749 K $42.24 Dec 20, 2023 Direct
Stock Option (Right to Buy) 20,012 Feb 6, 2023 Direct Common Stock

Transactions reported by Mark Bodenrader for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership